Search clinical trials for: Pitavastatin, Valsartan

Total 725 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

HIV Infections | Lipodystrophy

United States, Puerto Rico
Brigham and Women's Hospital
Novartis Pharmaceuticals

Withdrawn

Comparing ARNI With ACE Inhibitor on Endothelial Function (PARADOR)

Heart Failure With Reduced Ejection Fraction
IlDong Pharmaceutical Co Ltd

Completed

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan (IDCV)

Hypertension
Novartis

Completed

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.

Hypertension

Germany
Trinity Hypertension & Metabolic Research Institute
Allergan Sales, LLC

Completed

Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH (BVreduce)

Blood Pressure | Hypertrophy, Left Ventricular | Hypertension Complicated

United States
Novartis

Completed

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

Hypertension

United States, Germany
LG Life Sciences

Completed

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Organon and Co
Merck Sharp & Dohme LLC

Completed

Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

Hypercholesterolemia
Emory University

Completed

Effect of Valsartan on Carotid Artery Disease

Atherosclerosis | Carotid Artery Diseases

United States
Mitsukoshi Health and Welfare Foundation
Daiichi Sankyo Co., Ltd.; Ministry of Health, Labour and Welfare, Japan

Completed

Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)

Hyperlipidemia
University of Maryland, Baltimore
Medtronic

Withdrawn

Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

Hypertension | Congestive Heart Failure
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction (PARAGON-HF)

Heart Failure With Preserved Ejection Fraction

China, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
Novartis

Terminated

Antialbuminuric Effects of Valsartan and Lisinopril

Hypertension | Early Diabetic Nephropathy

Switzerland
Hanlim Pharm. Co., Ltd.

Completed

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Healthy Male Volunteers

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
Farma de Colombia SA

Completed

Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

Hypertension

Colombia, Ecuador
Oslo University Hospital

Recruiting

Infectious Pseudochromdrosis Caused by Bacillus Cereus (Blue sweat)

Infectious Disease | Bacterial Overgrowth | Pigment Deposition

Norway
Dr. Robert F. Casper

Withdrawn

Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis

Endometriosis

Canada
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 40 mg Tablets Food Challenge Study

Healthy

Canada
AstraZeneca

Completed

A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin

Drug Interaction

Sweden
Asan Medical Center
Novartis

Completed

Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation (PRIME)

Mitral Valve Insufficiency | Left Ventricular Dysfunction

Korea, Republic of
Assaf-Harofeh Medical Center

Unknown

Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

Hypertension
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

Hypertension

Spain, Italy, Netherlands, United States, Denmark, Taiwan, Argentina, Germany, Russian Federation, Slovakia, Canada, Hungary, Latvia, Lithuania, Poland, Finland, France, Sweden
Teva Pharmaceuticals USA

Completed

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Tokyo University

Completed

Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)

Diabetes Mellitus | Glucose Intolerance

Japan
Hamamatsu University

Completed

Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers (H-17-21)

Healthy Volunteers

Japan
Novartis Pharmaceuticals

Completed

Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers

Hypertension

Russian Federation
Novartis Pharmaceuticals

Completed

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

Chronic Heart Failure

Poland, Netherlands, United States, Argentina, Spain, Singapore, Italy, India, Russian Federation, Canada, Romania, Brazil, Venezuela, Germany
Seattle Institute for Biomedical and Clinical Research

Completed

Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

Aging | Alzheimer's Disease

United States
Centre Hospitalier Universitaire Dijon

Completed

Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

Child-Pugh A Hepatocellular Carcinoma

France
National Medical Research Center for Cardiology...
Ministry of Health of Russian Federation

Recruiting

LCZ696 in Advanced LV Hypertrophy and HFpEF

Heart Failure | Essential Hypertension

Russian Federation
Novartis Pharmaceuticals

Completed

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Systolic Hypertension

United States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
Novartis Pharmaceuticals

Completed

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction (EVALUATE-HF)

Heart Failure and Reduced Ejection Fraction

United States
RenJi Hospital

Unknown

Early Treatment of ARNI on Myocardial Remodeling and Progress

Myocardial Infarction

China
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Essential Hypertension

Turkey
LG Life Sciences

Completed

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

Hyperlipidemia | Hypertension,

Korea, Republic of
HK inno.N Corporation

Unknown

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
60P Australia Pty Ltd

Not yet recruiting

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Infectious Disease | SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID 19 Disease | Mild to Moderate COVID 19 Disease
Pachankis, Yang I., M.D.
First Affiliated Hospital of Chongqing Medical University

Completed

Detoxification From the Lipid Tract

COVID-19 Vaccine Adverse Reaction

China
Prince of Songkla University

Recruiting

PK of Meropenem in Patients on Plasma Exchange

Autoimmune Diseases

Thailand
University of California, San Francisco
National Institute of General Medical Sciences (NIGMS)

Completed

Drug-Drug Interaction Study With Pravastatin and Cyclosporine

Healthy

United States
University Hospital, Bordeaux
Ministry of Health, France

Completed

Pravastatin and Protease Inhibitors in HIV-Infected Patients

HIV Infection | Hypercholesterolemia

France
Nantou Christian Hospital

Completed

Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus

Diabetes Mellitus, Type 2

Taiwan
Federico II University

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage

Hypertension | Ventricular Remodeling | Erectile Dysfunctions

Italy
University of Pavia

Unknown

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Essential Hypertension

Italy
University Medical Centre Ljubljana

Completed

Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination (AGE-ZT)

Atherosclerosis
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Healthy
The Cleveland Clinic

Recruiting

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study (SEAL-IT)

Stage D Heart Failure

United States
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

Healthy

Egypt

Search clinical trials for: Pitavastatin, Valsartan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations